LDHA inactivation, in turn, downregulated several other glycolytic genes indicating the compromised glycolytic capacity of IDH mutant brain tumor stem cells (BTSCs) which may contribute to their slow growth and a better prognosis. The gene discussed is IDH1; the disease is brain neoplasm.